Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Some cancer treatments can cause permanent hair loss.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Childhood cancer survivors need better skin care and sun protection.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Hair follicle stem cells can help treat ulcerative colitis in mice by releasing beneficial exosomes.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Skin problems can indicate different diseases inside the body.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.